Mining And Ores Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the Active Substance Fluorouracil (Efudix(R))

Oh-Biologika-2023-22 - Pegfilgrastim

Finished Medicinal Product Called Acarizax (Atc: V01aa03 - House Dust Mites)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V for the Active Ingredient Sirolimus

Drug Discount Contracts According to § 130A Paragraph 8 Sgb V in the Context of Open House Procedures

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Apremilast

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Vinorelbine (Exclusively Oral Dosage Forms), Atc L01ca04 for the Period September 1St, 2023 - August 31St, 2025

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Golimumab (Atc Code: L04ab06).

Development Teams for the National Education Platform

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Miglustat, Atc A16ax06 for the Period September 1St, 2023 - August 31St, 2025